Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Biodesix Inc.
DescriptionDroplet digital PCR-based test that analyses cell-free DNA in blood to detect EGFR, KRAS and BRAF mutations
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsTo genotype advanced non-small cell lung cancer (NSCLC) tumor
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today